Google's Gemini Puts Eyes on Volvo's EX60 to Decode Parking Signs
Google and Volvo integrate Gemini AI with external cameras on the EX60 SUV to interpret parking signs and surroundings, merging Android Automotive with multimodal AI.
Breaking developments and in-depth analysis of the AI landscape.
Google and Volvo integrate Gemini AI with external cameras on the EX60 SUV to interpret parking signs and surroundings, merging Android Automotive with multimodal AI.
Colossal Biosciences grows chickens in a 3D printed artificial egg. This article explores the technology, its implications for de-extinction, and what it means for biotech.
Elon Musk lost his lawsuit against OpenAI over its nonprofit contract. The ruling sets a precedent for AI company accountability and governance.
HPE Threat Labs reveals how cybercriminals have industrialized operations using automation and AI, enabling faster, larger, and more structured attacks in 2025.
Google enters its annual developer conference as a clear third place in the foundation model race. Analysis of its strategy and what it means for the industry.
A jury unanimously found against Elon Musk on all claims in his trial against Sam Altman, but the verdict is advisory and not legally binding on the judge.
A jury ruled against Elon Musk in his lawsuit against OpenAI, affirming the company's shift to a for-profit model did not breach its original mission.
Elon Musk's lawsuit against OpenAI challenges its for-profit pivot. The trial outcome may reshape AI governance, nonprofit missions, and ChatGPT's trajectory.
TechEx North America reveals the critical but often overlooked infrastructure, power, and security considerations for enterprise AI adoption.
The Musk v. Altman trial ended with a jury dismissal, but the real verdict is that AI governance remains in the hands of flawed founders, not accountable stewards.
Anthropic acquires Stainless, the SDK automation startup used by OpenAI and Google. Analysis of the strategic move and its impact on the AI developer ecosystem.
SandboxAQ integrates its drug discovery models with Claude, making advanced AI accessible to researchers without a PhD in computing.